MDCO - The Medicines Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
6.79B
Enterprise Value 3
7.34B
Trailing P/E
N/A
Forward P/E 1
-24.12
PEG Ratio (5 yr expected) 1
-0.70
Price/Sales (ttm)
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-41.67

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3337.63%
S&P500 52-Week Change 325.85%
52 Week High 384.98
52 Week Low 319.13
50-Day Moving Average 384.46
200-Day Moving Average 354.54

Share Statistics

Avg Vol (3 month) 34.34M
Avg Vol (10 day) 3N/A
Shares Outstanding 579.93M
Float 73.86M
% Held by Insiders 14.22%
% Held by Institutions 1117.08%
Shares Short (Dec 12, 2019) 425.18M
Short Ratio (Dec 12, 2019) 43.53
Short % of Float (Dec 12, 2019) 4104.38%
Short % of Shares Outstanding (Dec 12, 2019) 431.50%
Shares Short (prior month Nov 14, 2019) 425.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-13.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-517k
EBITDA -176.27M
Net Income Avi to Common (ttm)-238.21M
Diluted EPS (ttm)-3.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)268.38M
Total Cash Per Share (mrq)3.38
Total Debt (mrq)865M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.77
Book Value Per Share (mrq)-0.75

Cash Flow Statement

Operating Cash Flow (ttm)-198.34M
Levered Free Cash Flow (ttm)-120.15M